SCHEMBL30900148

SCHEMBL30900148

CCCCCCCCC(CCCCCC)C(=O)OCCCCCC(CCCCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)NCCCCOC(=O)CN(C)C(=O)C(CCCCCC)CCCCCCCC

nearest known ligand 0.34

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ TLR2 O60603 3/20 0.34
▸ TLR1 Q15399 3/20 0.34
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MMP2 P08253 1/20 0.31
▸ MMP9 P14780 1/20 0.31
▸ MMP12 P39900 1/20 0.31
▸ BCHE P06276 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30900231 1.00 TLR2 (0.34) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900159 1.00 TLR2 (0.34) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900235 0.98 TLR2 (0.32) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900218 0.96 TLR2 (0.33) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900226 0.93 TLR2 (0.33) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900164 0.91 TLR2 (0.32) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900213 0.91 TLR2 (0.32) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900155 0.89 MGLL (0.35) —
SCHEMBL30900179 0.86 LTA4H (0.32) TLR2TLR1NPC1RAB9ASMN1; SMN2
SCHEMBL30900223 0.86 LTA4H (0.32) TLR2TLR1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594293-A1 AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS Nanovation Therapeutics Inc. (CA) 2025-08-06 — — EP disclosed
WO-2024065043-A1 AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2024-04-04 — — WO disclosed
Send feedback